Skip to main content
Top
Published in: Current Dermatology Reports 4/2014

01-12-2014 | Pediatrics (R Sidbury, Section Editor)

Pediatric Dermatology Clinical-Pathologic Cases: A Spectrum of Purpuric Disorders of Childhood

Authors: Keith W Morley, Jennifer Huang, Birgitta A.R. Schmidt

Published in: Current Dermatology Reports | Issue 4/2014

Login to get access

Abstract

In the following sections, we will present three recent cases of pediatric purpura encountered on the inpatient dermatology consult service from a tertiary pediatric hospital. In all cases, the final diagnoses were established with dermatopathologic-clinical correlation and special stains.
Literature
1.
go back to reference Maguiness S et al. Bullous Henoch-Schonlein purpura in children: a report of 6 cases and review of the literature. Clin Pediatr. 2010;49:1033–7.CrossRef Maguiness S et al. Bullous Henoch-Schonlein purpura in children: a report of 6 cases and review of the literature. Clin Pediatr. 2010;49:1033–7.CrossRef
3.
go back to reference Saulsbury FT. Henoch-Schonlein purpura in children—report of 100 patients and review of the literature. Medicine. 1999;78:395–409.PubMedCrossRef Saulsbury FT. Henoch-Schonlein purpura in children—report of 100 patients and review of the literature. Medicine. 1999;78:395–409.PubMedCrossRef
4.
go back to reference Tizard EJ, Hamilton-Ayres MJ. Henoch Schonlein purpura. Arch Dis Chil Educ Prac Ed. 2008;93:1–8.CrossRef Tizard EJ, Hamilton-Ayres MJ. Henoch Schonlein purpura. Arch Dis Chil Educ Prac Ed. 2008;93:1–8.CrossRef
5.•
go back to reference Pohl M. Henoch-Schonlein purpura nephritis. Pediatr Nephrol. 2014. [Epub ahead of print]. Comprehensive review of the etiologies, prognoses, and treatments of HSP induced renal disease. Pohl M. Henoch-Schonlein purpura nephritis. Pediatr Nephrol. 2014. [Epub ahead of print]. Comprehensive review of the etiologies, prognoses, and treatments of HSP induced renal disease.
7.
go back to reference Shenoy M, Ognjanovic MV, Coulthard MG. Treating severe Henoch-Schonlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol. 2007;22:1167–71.PubMedCrossRef Shenoy M, Ognjanovic MV, Coulthard MG. Treating severe Henoch-Schonlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol. 2007;22:1167–71.PubMedCrossRef
8.•
go back to reference Muhammed M et al. Fusarium infection: report of 26 cases and review of 97 cases from the literature. Medicine. 2013;92(6):305–16. Largest case series to date describing different variations and manifestations of Fusarium infection.PubMedCrossRef Muhammed M et al. Fusarium infection: report of 26 cases and review of 97 cases from the literature. Medicine. 2013;92(6):305–16. Largest case series to date describing different variations and manifestations of Fusarium infection.PubMedCrossRef
9.
go back to reference Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis. 2002;35:909–20.PubMedCrossRef Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis. 2002;35:909–20.PubMedCrossRef
11.
go back to reference Vinh DC et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood. 2010;115:1519–29.PubMedCentralPubMedCrossRef Vinh DC et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood. 2010;115:1519–29.PubMedCentralPubMedCrossRef
12.••
go back to reference Hsu AP et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653–5. The initial paper to identify the GATA2 as the causative mutation underlying MonoMAC syndrome.PubMedCentralPubMedCrossRef Hsu AP et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011;118(10):2653–5. The initial paper to identify the GATA2 as the causative mutation underlying MonoMAC syndrome.PubMedCentralPubMedCrossRef
13.
14.
go back to reference Gee SN et al. Rapidly fatal multiorgan Langerhans cell histiocytosis in a neonate. Pediatr Derm. 2013;30(5):e85–6.CrossRef Gee SN et al. Rapidly fatal multiorgan Langerhans cell histiocytosis in a neonate. Pediatr Derm. 2013;30(5):e85–6.CrossRef
16.
go back to reference Stein S et al. Langerhans cell histiocytosis presenting in the neonatal period. Arch Pediatr Adolesc Med. 2001;155:778–83.PubMedCrossRef Stein S et al. Langerhans cell histiocytosis presenting in the neonatal period. Arch Pediatr Adolesc Med. 2001;155:778–83.PubMedCrossRef
17.
go back to reference Jaffe R. Is there a role for histopathology in predicting the clinical outcome in congenital and infant Langerhans cell disease? Pediatr Blood Cancer. 2009;53:924–5.PubMedCrossRef Jaffe R. Is there a role for histopathology in predicting the clinical outcome in congenital and infant Langerhans cell disease? Pediatr Blood Cancer. 2009;53:924–5.PubMedCrossRef
Metadata
Title
Pediatric Dermatology Clinical-Pathologic Cases: A Spectrum of Purpuric Disorders of Childhood
Authors
Keith W Morley
Jennifer Huang
Birgitta A.R. Schmidt
Publication date
01-12-2014
Publisher
Springer US
Published in
Current Dermatology Reports / Issue 4/2014
Electronic ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-014-0087-9

Other articles of this Issue 4/2014

Current Dermatology Reports 4/2014 Go to the issue

Pediatrics (R Sidbury, Section Editor)

What’s New in Pediatric Dermatology